Aytu BiopharmaAYTU
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 29 institutions reported holding Aytu Biopharma Inc. (AYTU) in their 13F filings, up 5 from Q3 2024. 6 opened new positions and 2 sold out. The largest holders were Nantahala Capital Management, LLC ($1.8M), Stonepine Capital Management, LLC ($693K) and Armistice Capital, LLC ($255K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aytu Biopharma Inc.
- CUSIP
- 054754858
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $62K |
| Exits | 2 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 39,865 shares bought and 207,484 shares sold, net −167,619 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Nantahala Capital Management, LLC | 0.13% | No change | 1,086,812 | $1.8M |
| Stonepine Capital Management, LLC | 0.56% | Reduce -18.6% | 407,549 | $693K |
| Armistice Capital, LLC | 0.01% | Reduce -36.4% | 150,000 | $255K |
| Renaissance Technologies | 0.00% | Add +0.9% | 75,423 | $128K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.3% | 42,733 | $71K |
| Vanguard Group Inc. | 0.00% | No change | 27,888 | $47K |
| BlackRock, Inc. | 0.00% | No change | 22,793 | $39K |
| Acadian Asset Management LLC | 0.00% | No change | 14,622 | $24K |
| Two Sigma Securities, LLC | 0.00% | New | 11,690 | $20K |
| Citadel Advisors | 0.00% | New | 11,062 | $18K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -50.0% | 10,926 | $18K |
| Millennium Management | 0.00% | New | 10,369 | $17K |
| MAI Capital Management | 0.00% | New | 3,575 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +78.0% | 2,622 | $4K |
| UBS Group AG | 0.00% | Add +475.4% | 1,496 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $510 |
| Morgan Stanley | 0.00% | No change | 290 | $493 |
| Wells Fargo & Company | 0.00% | No change | 124 | $210 |
| Bank of America Corp. | 0.00% | Add +2.0% | 100 | $170 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 83 | $148 |
| JPMorgan Chase & Co. | 0.00% | Reduce -76.0% | 75 | $125 |
| SBI Securities Co., Ltd. | 0.00% | — | 61 | $104 |
| US Bancorp \de | 0.00% | Add +1800.0% | 57 | $97 |
| Group One Trading LLC | 0.00% | No change | 37 | $62 |
| BNP Paribas Financial Markets | 0.00% | New | 23 | $39 |
| NewEdge Advisors, LLC | 0.00% | No change | 21 | $36 |
| Credit Agricole S A | 0.00% | New | 5 | $9 |
| SJS Investment Consulting Inc. | 0.00% | No change | 5 | $9 |
| Tsfg, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AYTU's weight in each manager's 13F, not the share of Aytu Biopharma Inc. the manager owns.